Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

NCT00143559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Myeloid Leukemia
Juvenile Myelomonocytic Leukemia
Myelodysplastic Syndrome
Paroxysmal Nocturnal Hemoglobinuria
Hodgkin's Lymphoma
Non-Hodgkin Lymphoma

Interventions

DRUG: Systematic chemotherapy and antibodies
PROCEDURE: Allogeneic stem cell transplantation
DEVICE: Miltenyi CliniMACS

Sponsor

St. Jude Children's Research Hospital